TVM Capital Life Science

🏷️ vc
Visit Website ↗
Investment Thesis

TVM Capital Life Science invests in transformative life science innovations, leveraging a two-pronged strategy: financing early-stage therapeutics through a partnership with Eli Lilly and investing in differentiated commercial-stage medtech, diagnostics, digital health, and late-stage therapeutics. The firm focuses on AI-driven drug development and building value through close partnerships with portfolio companies.

Stage Focus
Early-stage therapeutics (via strategic partnership with Eli Lilly), commercial-stage medtech, diagnostics, digital health, and late-stage therapeutics

Preferred startup development maturity for initial funding deployment.

Sectors & Themes

Breakthrough therapies, medical products, AI-driven drug development, early-stage therapeutics, commercial-stage medtech, diagnostics, and digital health

Core thematic spaces, technologies, and target market segments of interest.

Check Size Range
€17,000,000 - €21,000,000

Standard financial allocation per investment round.

Outreach & Dossier Intelligence

Direct Verification Contact Email Pattern

[email protected] | [email protected]

Thesis Dossier Analysis Scorecard

Our agent analyzer scanned portfolio holdings and verified absolute match parameters...

Unlock Verified Partner Contacts

Find verified email templates, direct outreach copy created by AI, and calculate exact thesis match scores with 1-click.

Create Free Account to Unlock

Takes less than 30 seconds · No card required

Investment Team (33)